Talis Biomedical Corp - COM NEW (TLIS)

Historical Portfolio Holders from Q2 2023 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q3 2024
249K
Holdings value Q3 2024
$460K
Value change Q3 2024
-$6.05M
Grand Portfolio weight change Q3 2024
0%
Number of holders
2
Number of buys Q3 2024
1
Number of sells Q3 2024
-15
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 249K $460K -$6.05M $1.85 2
2024 Q2 789K $6.84M -$26.8K $8.66 18
2024 Q1 793K $6.93M -$20.7K $8.75 18
2023 Q4 797K $5.93M +$418K $7.45 18
2023 Q3 741K $4.27M -$39.7M $5.77 18
2023 Q2 7.63M $3.66M +$3.66M $0.48 2